(Finance) – Antares Visiona company listed on Euronext STAR Milan and active in the sector of quality control and product traceability, is technological partner of excellence in three research and innovation projects funded by the European Union, through the program NextGenerationEU, for a total value of approximately 900 million euros. “For the realization of these projects, the group makes available its know-how, the expertise and the ecosystem of its technological solutions: from traceability, to inspection for quality control, up to the integration of data also with application of artificial intelligence, “he commented Emidio Zorzellachairman and co-chief executive officer.
Within Life Science, has signed an agreement as founder with the National Research Center “Development of gene therapy and drugs with RNA technology” of Padua, financed for 400 million euros. In the field AgriTechhas signed an agreement with the National Research Center for “Agricultural Technologies – Agritech” at the University of Naples Federico II, financed for 477 million euros.
Finally, in the sector Digital Healthcare, has signed an agreement with the University of Brescia and Dompè Farmaceutici for the development of an integrated system of health infrastructures. The project is the result of a public and private partnership called LIGHT (Lifescience Innovation Good Healthcare Technology), which raised € 19.5 million in funds.
“The goal is to offer one technological platform to guarantee the safety, transparency, efficiency and sustainability of products, processes and supply chains – added Zorzella – The added value of these collaborations inaugurates a new paradigm for creating a system between companies and organizations of excellence thanks to technology, aimed at guaranteeing innovation for people’s health and safety and therefore a better quality of life “.